True Vision MN LLC Boosts Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

True Vision MN LLC lifted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 41.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 37,030 shares of the pharmacy operator’s stock after buying an additional 10,863 shares during the period. True Vision MN LLC’s holdings in Walgreens Boots Alliance were worth $332,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Clifford Capital Partners LLC increased its position in shares of Walgreens Boots Alliance by 9.9% in the third quarter. Clifford Capital Partners LLC now owns 882,549 shares of the pharmacy operator’s stock valued at $7,908,000 after acquiring an additional 79,345 shares during the period. Glenmede Trust Co. NA grew its stake in shares of Walgreens Boots Alliance by 82.5% in the third quarter. Glenmede Trust Co. NA now owns 40,268 shares of the pharmacy operator’s stock worth $361,000 after purchasing an additional 18,199 shares during the last quarter. Bridgewater Associates LP bought a new position in Walgreens Boots Alliance during the 3rd quarter valued at approximately $160,000. Brooklyn Investment Group purchased a new stake in Walgreens Boots Alliance in the 3rd quarter worth approximately $35,000. Finally, FMR LLC grew its position in shares of Walgreens Boots Alliance by 2.5% in the 3rd quarter. FMR LLC now owns 3,258,919 shares of the pharmacy operator’s stock worth $29,200,000 after buying an additional 80,525 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on WBA shares. JPMorgan Chase & Co. decreased their target price on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Barclays raised their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research report on Wednesday, October 16th. Bank of America reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a research report on Wednesday, September 4th. Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a report on Monday, October 7th. Finally, UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Stock Down 3.6 %

Shares of Walgreens Boots Alliance stock traded down $0.33 during midday trading on Wednesday, hitting $8.73. The company had a trading volume of 17,438,130 shares, compared to its average volume of 19,856,136. The company has a 50 day moving average of $9.13 and a 200 day moving average of $11.39. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.03. The firm had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The company’s revenue was up 5.9% on a year-over-year basis. During the same period last year, the company earned $0.67 earnings per share. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 11.45%. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.